Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042)
02/2003
02/27/2003WO2003015505A2 An animal model exhibiting cancer, pulmonary emphysema and cardiomyopathy
02/27/2003WO2002100348A3 Human monoclonal antibodies to epidermal growth factor receptor (egfr)
02/27/2003WO2002097046A3 B7 related protein-2 molecules and uses thereof
02/27/2003WO2002080851A3 Chimeric vaccines
02/27/2003WO2002072017A3 Method of drug target validation
02/27/2003WO2002042436A3 Isolated human phosphatase proteins, nucleic acid molecules encoding them, and uses thereof
02/27/2003WO2002030471A3 A novel system for the evaluation of the activity and/or specificity of a viral component
02/27/2003WO2002016548A8 Novel g protein-coupled receptor
02/27/2003WO2002008407A9 Gene-targeted non-human mammal with human fad presenilin mutation and generational offspring
02/27/2003WO2002001950A3 Transgenic mice containing targeted gene disruptions
02/27/2003US20030041341 Non-human transgenic animal whose germ cells and somatic cells contain a knockout mutation in DNA encoding 4E-BP1
02/27/2003US20030041339 Animal model for use in the treatment of vision defects
02/27/2003US20030041337 Animal model for use in the diagnosis and treatment of diabetic phenotype
02/27/2003US20030040052 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of human cancers
02/27/2003US20030039999 B7 related protein-2 molecules and uses thereof
02/27/2003US20030039984 Sequences upstream of the CARP gene, vectors containing them and uses thereof
02/27/2003US20030039737 Population of dairy cows producing milk with desirable characteristics and methods of making and using same
02/27/2003CA2458193A1 Development of transgenic model for interventions in neurodegenerative diseases
02/27/2003CA2457317A1 Transgenic rodents as animal models for modulation of b1 bradykinin receptor protein
02/27/2003CA2456340A1 Propagation of human hepatoblastoma cell in non-human animals
02/26/2003EP1285967A2 Human retroviral packaging cell line
02/26/2003EP1285578A2 Transgenic animal model of Alzheimer's disease
02/26/2003EP1285577A1 Chimeric mouse having an immune system constructed with human cd34-positive cells and use thereof
02/26/2003EP1285272A2 Compositions and methods for screening therapeutic agents
02/26/2003EP1285063A1 Anti-angiogenic polypeptides
02/26/2003EP1285058A2 Fertilization of aged oocytes
02/26/2003EP1284649A2 A method and apparatus for detecting lameness in animals
02/26/2003EP0770137B1 Improvements in production of proteins in host cells
02/26/2003CN2537217Y Cultivation device suitable for automatic cultivating crabs
02/26/2003CN1399685A 蛋白质生产系统 Protein Production System
02/26/2003CN1399645A Human monolonal antibodies to HER2/NEU
02/26/2003CN1399644A Novel human G-Protein coupled receptor
02/26/2003CN1399514A Model animal of mesangial cell proliferative nephritis
02/26/2003CN1399513A Preparation and selection of donor cells for nuclear transplantation
02/25/2003US6525243 Unactivated oocytes as cytoplast recipients of quiescent cell nuclei while maintaining correct ploidy
02/25/2003US6525242 Preparation of non-human animals having chimeric livers for use of animal models for human liver toxins; immunocompetent animals are rendered tolerant to human hepatocytes by cell or lysate administration during embryonic or neonate stage
02/25/2003US6525241 Expression methods
02/25/2003US6524860 Methods for improving sheath fluids and collection systems for sex-specific cytometer sorting of sperm
02/25/2003US6524819 And their use in the screening for compounds of use in characterization, diagnosis, and treatment of conditions such as Alzheimer's disease, Down syndrome and other forms of dementia
02/25/2003US6524815 A promoter which is active in the vascular endothelium and to its use for expressing genes of interest in this tissue
02/25/2003US6524571 Methioninase gene therapy for tumor treatment
02/20/2003WO2003014731A2 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use
02/20/2003WO2003014383A2 Phenotypic effects of ubiquinone deficiencies and methods of screening thereof
02/20/2003WO2003014298A2 Full-length prostate selective polynucleotides and polypeptides
02/20/2003WO2003014153A2 Cellular virus receptors and methods of use.
02/20/2003WO2003013429A2 A programmable electronic maze for use in the assessment of animal behaviour
02/20/2003WO2003013234A2 Method for the in vivo screening of the biological activity of an acetylcholinesterase inhibitor compound on one or more cellular targets other than acetylcholinesterase
02/20/2003WO2002094874A3 Internalisation of virus into cells
02/20/2003WO2002094862A3 Hypoxia inducible factors and uses thereof for inducing angiogenesis and improving muscular functions
02/20/2003WO2002092758A8 Gastrokines and derived peptides including inhibitors
02/20/2003WO2002029075A9 Multiple inducible gene regulation system
02/20/2003WO2002026193A9 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
02/20/2003WO2002022783A8 Liver gene expression associated with the inhibition of hbv replication or transcription
02/20/2003WO2001072325A9 Methods of blocking tissue destruction by autoreactive t cells
02/20/2003WO2001053538A3 Method for functional mapping of an alzheimer's disease gene network and for identifying therapeutic agents for the treatment of alzheimer's disease
02/20/2003US20030037354 Animal model for use in the diagnosis and treatment of nervous system disorders
02/20/2003US20030037352 Generation of genetically engineered animal embryos; obtain oocyte, insert into diploid nucleus, activate oocyte, propagate and recover viable offspring
02/20/2003US20030037349 Method for combinatorial optimization in plant or animal breeding
02/20/2003US20030037348 Genetic manipulation of spermatogonia
02/20/2003US20030037347 Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates
02/20/2003US20030037346 Protein production system
02/20/2003US20030037345 Compositions and methods for wound healing
02/20/2003US20030036184 Polypeptides exhibiting PDE7 activity and their use for selecting compounds which inhibit PDE 7 enzyme activity
02/20/2003US20030036167 Protease proteins that are related to the choriolytic hatching protease subfamily, recombinant DNA molecules, and protein production.
02/20/2003CA2467919A1 Methods and compounds for disruption of cd40r/cd40l signaling in the treatment of alzheimer's disease
02/20/2003CA2456928A1 Cellular virus receptors and methods of use
02/20/2003CA2456565A1 Phenotypic effects of ubiquinone deficiencies and methods of screening thereof
02/19/2003EP1284298A2 Identification and use of molecules implicated in pain
02/19/2003EP1284297A2 Identification and use of molecules implicated in pain
02/19/2003EP1283882A1 Ssa-56kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
02/19/2003CN2536037Y Biological honeycomb style raising shed for forest clam
02/19/2003CN1398300A Novel elongase gene and method for producing multiple-unsaturated fatty acids
02/19/2003CN1397160A Hybridization technique between different kinds of sea urchin
02/19/2003CN1397159A Technology for industrially culturing trichogramma with gelechiid ova
02/18/2003US6521815 Screening for putative agents; cells with higher epidermal expression of protein kinase C; inducing tumors, metastasis, and/or cancer
02/18/2003US6521417 Incubating permeabilized cells expressing mutant kinase with radiolabeled analog; cytolysis, separation by sodium dodecyl sulfate polyacrylamide gel electrophoresis
02/18/2003US6521412 Drug screening for anticarcinogenic agents and agents to treat atherosclerosis and neurodegenerative disorders
02/18/2003US6519954 Cryogenic preservation of biologically active material using high temperature freezing
02/13/2003WO2003012394A2 Androgen receptor knock-out transgenic animals
02/13/2003WO2003012143A1 Genes and snps associated with eating disorders
02/13/2003WO2003012126A2 Epoxide hydrolases, nucleic acids encoding them and methods for making and using them
02/13/2003WO2003012064A2 Nucleic acids and encoded polypeptides associated with bipolar disorder
02/13/2003WO2003012062A2 Animal model with disrupted fgf14 gene
02/13/2003WO2003012041A2 Knock in transgenic mammal containing a non-functional n-terminus of kv beta 1.1 subunit
02/13/2003WO2003011900A1 Protein regulating the kinetics of actin cell skeleton system and utilization thereof
02/13/2003WO2003011332A1 Methods relating to improved polyepitope vaccination strategies
02/13/2003WO2003011331A2 Materials and methods relating to improved vaccination strategies
02/13/2003WO2003011171A2 Apparatus for detecting estrus in livestock
02/13/2003WO2002074345B1 Immune modulation by transduced hematopoietic stem cells expressing antigens and antigen-presenting cell regulatory molecules
02/13/2003WO2002072551A3 A non-traumatic model for neurogenic pain
02/13/2003WO2002070648A3 Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates
02/13/2003WO2002069907A3 Anti-neovasculature preparations for cancer
02/13/2003WO2002031115A3 Nucleic acid molecules and polypeptides for immune modulation
02/13/2003WO2002020752A3 Cloned cells, embryos, and avians and methods, of producing them
02/13/2003WO2002016594A3 Methods and reagents for molecular cloning
02/13/2003WO2001094951A9 Inhibitors of c-reactive protein induced inflammation
02/13/2003WO2001092567A3 Novel target genes for diseases of the heart
02/13/2003WO2001067855A3 Transgenic mice containing targeted gene disruptions
02/13/2003US20030033623 Animal model for use in the treatment and diagnosis of nervous system disorders
02/13/2003US20030033622 Generation of trangeenic insects; obtain embryo, inject with transposable expression vector coding heterologous protein, detect insertion of sequences into embryonic genome, expression of reporter molecule indicates insertion